735 Contribution of Alkylating Agents in the Cytogenetic Diagnosis of Fanconi Anemia. (October 2012)

• Record Type: Journal Article
• Authors: Bouraoui, S; Mougou, S; Mamai, O; Elghezal, H; Saad, A
• Is Part Of: Archives of disease in childhood. Volume 97(2012)Supplement 2
• Page Start: A212
• Page End: A212
• Publication Date: 2012-10
• Subjects: Children -- Diseases -- Periodicals; Infants -- Diseases -- Periodicals; 618.920005
• DOI: 10.1136/archdischild-2012-302724.0735
• Languages: English
• ISSNs: 0003-9888

Abstract

Abstract : Background and Aims: Fanconi Anemia (FA) is an autosomal recessive disease characterized by heterogenous phenotype which includes a bone marrow failure, diverse abnormalities and increased predisposition to develop leukemia. The cytogenetic diagnosis of FA cells to bifunctional alkylating agents, resulting in greatly increased chromosomal breakage and radial stuctures induced by cross-linking agents. To estimate the sensitivity and the specificity of the Mitomicyn C (MMC) and the Diepoxybutan (DEB), two alkylating agents used in the diagnosis of the FA, we studied the chromosomal instability on 22 patients using variable types and concentrations of these alkylating (25 and 40 ng/ml of MMC, 0.1µg/ml of DEB). Methods: Heparanized venous blood samples were collected and were processed for the cytogenetic methodology in this study. After culture, 100 of metaphases were analysed to evaluate the frequency of chromosomal aberrations. Results: The MMC test at 25ng/ml was High sensitive for FA. The DEB test showed a better specificity. The study of the mitotic segregation of sexual chromosomes by FISH took away any abnormality of the segregation to cells FA. Conclusions: A molecular study of the sensivity and the specificity of the alkylating agents used according to the group of complementation will come refine the diagnosis of FA by establishing a gold standard.